{"nct_id":"NCT04241185","title":"Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2020-05-19","start_date_type":"ACTUAL","primary_completion_date":"2027-01-31","primary_completion_date_type":"ESTIMATED","completion_date":"2031-11-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}